Stock analysis, AI verdict, fundamentals & technical signals
Rating: SELL AI Verdict: SKIP
Price: $413.75 Analyst target: $482.38 Upside: 16.59%
ELV has run from the SMA50 (367) to 439.95, breaking above the 3m resistance (434) and the upper Bollinger band (436.09), with CCI at 207 and Williams %R at -12, so it is extended going into the Oct 21 Q3 earnings. Momentum is a Guggenheim target raise to $460 and a recovery rally, but earnings growth is -13% YoY, the profit margin is thin at 2.5%, and the preview flags lower premiums as a risk. Entry here is a chase into a binary event, not an oversold dip.
Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.
See the full interactive analysis & chart →Informational only — not investment advice.